At the beginning of the new year, Hamlet Protein CEO Erik Visser discusses the 2023 market outlook for the animal nutrition industry in general and for Hamlet Protein in particular. The global specialty ingredients for young animal nutrition company expects volatility and high feed costs to continue, yet sees opportunities for growth in swine and poultry markets.
"If 2022 has taught us anything, it is that making predictions is incredibly difficult, nevertheless I will attempt to look ahead on what we can expect from the markets in the coming year," said Hamlet Protein CEO Erik Visser.